FR2730492B1 - Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent - Google Patents
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennentInfo
- Publication number
- FR2730492B1 FR2730492B1 FR9501490A FR9501490A FR2730492B1 FR 2730492 B1 FR2730492 B1 FR 2730492B1 FR 9501490 A FR9501490 A FR 9501490A FR 9501490 A FR9501490 A FR 9501490A FR 2730492 B1 FR2730492 B1 FR 2730492B1
- Authority
- FR
- France
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- transferase inhibitors
- farnesyl transferase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9501490A FR2730492B1 (fr) | 1995-02-09 | 1995-02-09 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
BR9607318A BR9607318A (pt) | 1995-02-09 | 1996-02-07 | Peptidos e composição farmacêutica |
EP96903062A EP0808329A1 (fr) | 1995-02-09 | 1996-02-07 | Inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
AU47228/96A AU4722896A (en) | 1995-02-09 | 1996-02-07 | Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same |
JP8524038A JPH10513468A (ja) | 1995-02-09 | 1996-02-07 | ファルネシル転移酵素阻害剤、これらの調製、及びこれらを含む製薬学的組成 |
KR1019970705444A KR19980702049A (ko) | 1995-02-09 | 1996-02-07 | 신규한 파르네실 트랜스퍼라아제 억제제, 이의 제조방법 및 이를 함유하는 약학 조성물 |
TR97/00726T TR199700726T1 (xx) | 1995-02-09 | 1996-02-07 | Farnezil transferaz �nleyiciler ve m�stahzarlar�. |
PCT/FR1996/000199 WO1996024612A1 (fr) | 1995-02-09 | 1996-02-07 | Inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
CN96191866A CN1173873A (zh) | 1995-02-09 | 1996-02-07 | 新的法呢基转移酶抑制剂,其制法及其药物组合物 |
CZ972499A CZ249997A3 (en) | 1995-02-09 | 1996-02-07 | Novel inhibitors of farnesyl transferase, process of their preparation and pharmaceutical compositions containing such inhibitors |
CA002210953A CA2210953A1 (fr) | 1995-02-09 | 1996-02-07 | Inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
PL96321710A PL321710A1 (en) | 1995-02-09 | 1996-02-07 | Novel inhibitors of farnseferase, their production and pharmaceutic compositions containing them |
SK1088-97A SK108897A3 (en) | 1995-02-09 | 1996-02-07 | Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same |
ZA961073A ZA961073B (en) | 1995-02-09 | 1996-02-09 | New farnesyl transferase inhibitors their preparation and the pharmaceutical compositions which contain them |
MXPA/A/1997/005969A MXPA97005969A (en) | 1995-02-09 | 1997-08-05 | New farnesil inhibitors transfer your preparation and the pharmaceutical compositions that contain them |
NO973607A NO973607D0 (no) | 1995-02-09 | 1997-08-05 | Nye farnesyltransferaseinhibitorer, deres fremstilling og preparater inneholdende inhibitorene |
FI973279A FI973279A0 (fi) | 1995-02-09 | 1997-08-08 | Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9501490A FR2730492B1 (fr) | 1995-02-09 | 1995-02-09 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2730492A1 FR2730492A1 (fr) | 1996-08-14 |
FR2730492B1 true FR2730492B1 (fr) | 1997-03-14 |
Family
ID=9475981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9501490A Expired - Fee Related FR2730492B1 (fr) | 1995-02-09 | 1995-02-09 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0808329A1 (fr) |
JP (1) | JPH10513468A (fr) |
KR (1) | KR19980702049A (fr) |
CN (1) | CN1173873A (fr) |
AU (1) | AU4722896A (fr) |
BR (1) | BR9607318A (fr) |
CA (1) | CA2210953A1 (fr) |
CZ (1) | CZ249997A3 (fr) |
FI (1) | FI973279A0 (fr) |
FR (1) | FR2730492B1 (fr) |
NO (1) | NO973607D0 (fr) |
PL (1) | PL321710A1 (fr) |
SK (1) | SK108897A3 (fr) |
TR (1) | TR199700726T1 (fr) |
WO (1) | WO1996024612A1 (fr) |
ZA (1) | ZA961073B (fr) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2730491B1 (fr) * | 1995-02-09 | 1997-03-14 | Rhone Poulenc Rorer Sa | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
US5932590A (en) * | 1996-12-05 | 1999-08-03 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6015817A (en) * | 1996-12-05 | 2000-01-18 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5977134A (en) * | 1996-12-05 | 1999-11-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5972966A (en) * | 1996-12-05 | 1999-10-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
FR2796943A1 (fr) * | 1999-07-30 | 2001-02-02 | Aventis Pharma Sa | Derives de benzoxazinnes, leur procede de preparation et leur utilisation en therapeutique |
FR2796946A1 (fr) * | 1999-07-30 | 2001-02-02 | Aventis Pharma Sa | Nouveaux derives 8-carbonyl chromanes, leur preparation et leur utilisation en therapeutique |
ES2382814T3 (es) | 2005-05-17 | 2012-06-13 | Merck Sharp & Dohme Ltd. | Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
CA2770486C (fr) | 2006-09-22 | 2014-07-15 | Merck Sharp & Dohme Corp. | Utilisation de la platencine et de la platensimycine en tant qu'inhibiteurs de la synthese des acides gras pour traiter l'obesite, lediabete et le cancer |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
PL2109608T3 (pl) | 2007-01-10 | 2011-08-31 | Msd Italia Srl | Indazole podstawione grupą amidową jako inhibitory polimerazy poli(ADP-rybozy)-(PARP) |
US8822497B2 (en) | 2007-03-01 | 2014-09-02 | Novartis Ag | PIM kinase inhibitors and methods of their use |
WO2008144062A1 (fr) | 2007-05-21 | 2008-11-27 | Novartis Ag | Inhibiteurs du csf-1r, compositions et procédés d'utilisation |
JP5501227B2 (ja) | 2007-06-27 | 2014-05-21 | メルク・シャープ・アンド・ドーム・コーポレーション | ヒストンデアセチラーゼ阻害剤としての4−カルボキシベンジルアミノ誘導体 |
WO2010114780A1 (fr) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibiteurs de l'activité akt |
WO2010144909A1 (fr) | 2009-06-12 | 2010-12-16 | Novartis Ag | Composés hétérocycliques fondus et leurs utilisations |
US8859776B2 (en) | 2009-10-14 | 2014-10-14 | Merck Sharp & Dohme Corp. | Substituted piperidines that increase p53 activity and the uses thereof |
AU2011227643A1 (en) | 2010-03-16 | 2012-09-20 | Dana-Farber Cancer Institute, Inc. | Indazole compounds and their uses |
EP2584903B1 (fr) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Nouveaux composés hétérocycliques utilisés comme inhibiteurs de erk |
JP6043285B2 (ja) | 2010-08-02 | 2016-12-14 | サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. | 低分子干渉核酸(siNA)を用いたカテニン(カドヘリン結合型タンパク質)β1(CTNNB1)遺伝子発現のRNA干渉媒介性阻害 |
RU2624045C2 (ru) | 2010-08-17 | 2017-06-30 | Сирна Терапьютикс,Инк | ОПОСРЕДУЕМОЕ РНК-ИНТЕРФЕРЕНЦИЕЙ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ ГЕНОВ ВИРУСА ГЕПАТИТА B (HBV) С ПРИМЕНЕНИЕМ МАЛОЙ ИНТЕРФЕРИРУЮЩЕЙ НУКЛЕИНОВОЙ КИСЛОТЫ (миНК) |
US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
EP2613782B1 (fr) | 2010-09-01 | 2016-11-02 | Merck Sharp & Dohme Corp. | Dérivés d'indazole utilisables en tant qu'inhibiteurs de la voie erk |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
EP2632472B1 (fr) | 2010-10-29 | 2017-12-13 | Sirna Therapeutics, Inc. | Inhibition facilitée par l'interférence d'arn de l'expression d'un gène au moyen d'acides nucléiques interférents courts (sina) |
WO2012087772A1 (fr) | 2010-12-21 | 2012-06-28 | Schering Corporation | Dérivés d'indazole utiles en tant qu'inhibiteurs de erk |
CN103732592A (zh) | 2011-04-21 | 2014-04-16 | 默沙东公司 | 胰岛素样生长因子-1受体抑制剂 |
US9023865B2 (en) | 2011-10-27 | 2015-05-05 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
US9382239B2 (en) | 2011-11-17 | 2016-07-05 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-Jun-N-terminal kinase (JNK) |
US20150299696A1 (en) | 2012-05-02 | 2015-10-22 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
CA2882950A1 (fr) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Nouveaux composes inhibiteurs de erk |
WO2014063068A1 (fr) | 2012-10-18 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de cycline-dépendante kinase 7 (cdk7) |
USRE48175E1 (en) | 2012-10-19 | 2020-08-25 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
RU2660349C2 (ru) | 2012-11-28 | 2018-07-05 | Мерк Шарп И Доум Корп. | Композиции и способы для лечения злокачественной опухоли |
WO2014100065A1 (fr) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Imidazopyridines substituées en tant qu'inhibiteurs de hdm2 |
WO2014120748A1 (fr) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | Purines 2,6,7,8-substituées utilisées en tant qu'inhibiteurs de hdm2 |
EP3041938A1 (fr) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Polynucléotides circulaires |
EP3057955B1 (fr) | 2013-10-18 | 2018-04-11 | Syros Pharmaceuticals, Inc. | Composes heteroaromatiques utiles dans le traitement de maladies proliferatives |
US10047070B2 (en) | 2013-10-18 | 2018-08-14 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
WO2015164614A1 (fr) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de janus kinase et leurs utilisations |
US9862688B2 (en) | 2014-04-23 | 2018-01-09 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
AU2015371251B2 (en) | 2014-12-23 | 2020-06-11 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
WO2016160617A2 (fr) | 2015-03-27 | 2016-10-06 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de kinases cycline-dépendantes |
EP3307728A4 (fr) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | Thérapie d'association utilisant des inhibiteurs de transcription et des inhibiteurs de kinases |
CA2996978A1 (fr) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de kinases cycline-dependantes |
JOP20190055A1 (ar) | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | أجسام مضادة ضد cd27 |
EP3609922A2 (fr) | 2017-04-13 | 2020-02-19 | Aduro Biotech Holdings, Europe B.V. | Anticorps anti-sirp alpha |
EP3706742B1 (fr) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Inhibiteurs de prmt5 |
WO2019148412A1 (fr) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anticorps bispécifiques anti-pd-1/lag3 |
US20210309688A1 (en) | 2018-08-07 | 2021-10-07 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
WO2020033282A1 (fr) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Inhibiteurs de prmt5 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141851A (en) * | 1990-04-18 | 1992-08-25 | Board Of Regents, The University Of Texas System | Isolated farnesyl protein transferase enzyme |
CA2072033A1 (fr) * | 1991-06-28 | 1992-12-29 | Jackson B. Gibbs | Inhibiteur de la farnesyl-proteine-transferase ne se rapportant pas a un substrat |
CA2118985A1 (fr) * | 1993-04-02 | 1994-10-03 | Dinesh V. Patel | Inhibiteurs heterocycliques de la farnesyl proteine transferase |
EP0763537A3 (fr) * | 1993-05-14 | 1997-10-22 | Genentech Inc | Inhibiteurs de la farnesyl-transferase non peptidiques |
US5439918A (en) * | 1994-03-14 | 1995-08-08 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
-
1995
- 1995-02-09 FR FR9501490A patent/FR2730492B1/fr not_active Expired - Fee Related
-
1996
- 1996-02-07 CZ CZ972499A patent/CZ249997A3/cs unknown
- 1996-02-07 SK SK1088-97A patent/SK108897A3/sk unknown
- 1996-02-07 WO PCT/FR1996/000199 patent/WO1996024612A1/fr not_active Application Discontinuation
- 1996-02-07 PL PL96321710A patent/PL321710A1/xx unknown
- 1996-02-07 JP JP8524038A patent/JPH10513468A/ja active Pending
- 1996-02-07 BR BR9607318A patent/BR9607318A/pt not_active Application Discontinuation
- 1996-02-07 TR TR97/00726T patent/TR199700726T1/xx unknown
- 1996-02-07 AU AU47228/96A patent/AU4722896A/en not_active Abandoned
- 1996-02-07 EP EP96903062A patent/EP0808329A1/fr not_active Withdrawn
- 1996-02-07 CA CA002210953A patent/CA2210953A1/fr not_active Abandoned
- 1996-02-07 KR KR1019970705444A patent/KR19980702049A/ko not_active Application Discontinuation
- 1996-02-07 CN CN96191866A patent/CN1173873A/zh active Pending
- 1996-02-09 ZA ZA961073A patent/ZA961073B/xx unknown
-
1997
- 1997-08-05 NO NO973607A patent/NO973607D0/no unknown
- 1997-08-08 FI FI973279A patent/FI973279A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1996024612A1 (fr) | 1996-08-15 |
MX9705969A (es) | 1997-11-29 |
CZ249997A3 (en) | 1997-11-12 |
FI973279A (fi) | 1997-08-08 |
CA2210953A1 (fr) | 1996-08-15 |
NO973607L (no) | 1997-08-05 |
PL321710A1 (en) | 1997-12-22 |
SK108897A3 (en) | 1997-12-10 |
EP0808329A1 (fr) | 1997-11-26 |
KR19980702049A (ko) | 1998-07-15 |
FR2730492A1 (fr) | 1996-08-14 |
JPH10513468A (ja) | 1998-12-22 |
ZA961073B (en) | 1996-08-20 |
AU4722896A (en) | 1996-08-27 |
FI973279A0 (fi) | 1997-08-08 |
NO973607D0 (no) | 1997-08-05 |
BR9607318A (pt) | 1997-12-30 |
TR199700726T1 (xx) | 1998-01-21 |
CN1173873A (zh) | 1998-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2736641B1 (fr) | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2730491B1 (fr) | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2736638B1 (fr) | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2730492B1 (fr) | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2742751B1 (fr) | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2727411B1 (fr) | Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent | |
DZ2009A1 (fr) | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. | |
FR2676446B1 (fr) | Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
FR2683531B1 (fr) | Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
FR2642069B1 (fr) | Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2732968B1 (fr) | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2779724B1 (fr) | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2757166B1 (fr) | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2687151B1 (fr) | Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
FR2745814B1 (fr) | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2732342B1 (fr) | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2712288B1 (fr) | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. | |
FR2712289B1 (fr) | Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent. | |
FR2721021B1 (fr) | Nouveaux inhibiteurs de farnésyl transférase, leur préparation et les compositions pharmaceutique qui les contiennent. | |
FR2705097B1 (fr) | Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent. | |
FR2705094B1 (fr) | Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent. | |
FR2721023B1 (fr) | Nouveaux Taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. | |
FR2757855B1 (fr) | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent | |
FR2733498B1 (fr) | Nouveaux composes cyclohexaniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2742753B1 (fr) | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |